Showing results (1591-1600 of 1,683) with videos related to

Sort By:
Pageof 169
Journal of Medicinal Chemistry|February 11, 2015
Discovery of 4'-chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infectionGuangyi Wang, Jerome Deval, Jin Hong, et al.
Haematologica|June 10, 2017
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemiaKaroline V Gleixner, Mathias Schneeweiss, Gregor Eisenwort, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 19, 2002
An analysis of acute changes in interleukin-6 levels after treatment of hepatitis C with consensus interferonS J Cotler, K R Reddy, J McCone, et al.
International Journal for Equity in Health|June 4, 2019
Judicialization of access to medicines in four Latin American countries: a comparative qualitative analysisClaudia Marcela Vargas-Pelaez, Marina Raijche Mattozo Rover, Luciano Soares, et al.
Social Science & Medicine (1982)|February 23, 2017
Towards a theoretical model on medicines as a health needClaudia Marcela Vargas-Peláez, Luciano Soares, Marina Raijche Mattozo Rover, et al.
Annals of Epidemiology|April 30, 2024
Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023Adam Z Blatt, Mina Suh, Emmanuel B Walter, et al.
Leukemia|September 10, 2015
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growthB Peter, G E Winter, K Blatt, et al.
Blood Advances|October 21, 2020
Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CMLHarald Herrmann, Irina Sadovnik, Gregor Eisenwort, et al.
Plos One|December 11, 2020
Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)Xuan G Luong, Sarah K Stevens, Andreas Jekle, et al.
Hepatology (Baltimore, Md.)|April 27, 2023
Class A capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferationDieudonné Buh Kum, Hannah Vanrusselt, Abel Acosta Sanchez, et al.
Pageof 169